• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内分泌危象。高钾血症。

Endocrine crises. Hyperkalemia.

作者信息

Williams M E

机构信息

New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

Crit Care Clin. 1991 Jan;7(1):155-74.

PMID:2007212
Abstract

Clinical disorders causing hyperkalemia require a basic understanding of normal K homeostasis, which consists of external and internal K balances. The kidney is predominant in maintaining the external balance of K, and a number of mechanisms exist to provide a renal adaptation to defend against K excess. Likewise, several factors are known to modulate internal K balance--i.e., its distribution within the body. Some of these factors may provide defense against hyperkalemia before the kidneys have time to adapt. Potassium retention by the kidney causes hyperkalemia when renal failure is advanced, or earlier in the face of impaired tubular function in a variety of disorders. Hyperkalemia out of proportion to loss of renal function also occurs in the syndrome of hyporeninemic hypoaldosteronism. Drug-induced hyperkalemia is increasingly common and usually is caused by nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors, cyclosporine, or K-sparing diuretics. Clinical disorders of internal K imbalance include diabetes mellitus, systemic acidosis, and use of beta-blockers. Hyperkalemia is usually asymptomatic, but the danger of cardiac arrest or arrhythmia in severe hyperkalemia forces prompt clinical attention. Available treatment choices include agents that antagonize the effect of K on membrane potentials, redistribute it internally into cells, and remove it altogether from the body. The diagnostic work-up can then proceed, first by distinguishing renal and extrarenal causes, then by examining the roles of specific factors outlined in the section on normal K homeostasis.

摘要

导致高钾血症的临床疾病需要对正常钾稳态有基本的了解,钾稳态包括外部和内部钾平衡。肾脏在维持钾的外部平衡中起主要作用,存在多种机制来实现肾脏适应性调节以抵御钾过量。同样,已知有几个因素可调节内部钾平衡,即钾在体内的分布。在肾脏有时间适应之前,其中一些因素可能对高钾血症起到防御作用。当肾衰竭进展时,或在各种疾病导致肾小管功能受损的早期,肾脏对钾的潴留会导致高钾血症。在低肾素性低醛固酮血症综合征中也会出现与肾功能丧失不成比例的高钾血症。药物性高钾血症越来越常见,通常由非甾体类抗炎药、血管紧张素转换酶抑制剂、环孢素或保钾利尿剂引起。内部钾失衡的临床疾病包括糖尿病、全身酸中毒和使用β受体阻滞剂。高钾血症通常无症状,但严重高钾血症时心脏骤停或心律失常的风险促使临床迅速关注。可用的治疗选择包括拮抗钾对膜电位作用的药物、将其在体内重新分布到细胞内以及将其完全从体内清除的药物。然后可以进行诊断检查,首先区分肾脏和肾外原因,然后检查正常钾稳态章节中概述的特定因素的作用。

相似文献

1
Endocrine crises. Hyperkalemia.内分泌危象。高钾血症。
Crit Care Clin. 1991 Jan;7(1):155-74.
2
[Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].[低肾素性低醛固酮血症与高钾血症的鉴别诊断]
Schweiz Med Wochenschr. 1982 Dec 4;112(49):1764-74.
3
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].[晚期慢性肾脏病中的电解质和酸碱平衡紊乱]
Nefrologia. 2008;28 Suppl 3:87-93.
4
[Hyperkalemias].[高钾血症]
Orv Hetil. 1999 Nov 21;140(47):2611-8.
5
Potassium and renal failure.钾与肾衰竭
Compr Ther. 1981 Mar;7(3):29-33.
6
Potassium homeostasis in chronic diabetes mellitus.慢性糖尿病中的钾稳态
Arch Intern Med. 1977 Aug;137(8):1018-22.
7
[Hyperkalemia].[高钾血症]
Schweiz Rundsch Med Prax. 1991 Jan 15;80(3):41-5.
8
Potassium homeostasis and hyperkalemic syndromes.钾稳态与高钾血症综合征
Endocrinol Metab Clin North Am. 1995 Sep;24(3):573-91.
9
Review of the pathophysiology of alterations in potassium homeostasis.钾稳态改变的病理生理学综述。
J Am Vet Med Assoc. 1986 May 1;188(9):1019-25.
10
Non-diuretic-based antihypertensive therapy and potassium homeostasis in elderly patients.
Coron Artery Dis. 1997 Aug-Sep;8(8-9):499-504.

引用本文的文献

1
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.在英国进行帕替罗默的成本效益分析:评估心力衰竭和无心力衰竭的慢性肾脏病患者中高钾血症的治疗和终生 RAASi 维持。
BMC Nephrol. 2023 Mar 9;24(1):47. doi: 10.1186/s12882-023-03088-3.
2
Clinical safety and outcomes of glucagon use during endoscopic retrograde cholangiopancreatography (ERCP).内镜逆行胰胆管造影术(ERCP)期间使用胰高血糖素的临床安全性及结果
Endosc Int Open. 2022 Apr 14;10(4):E558-E561. doi: 10.1055/a-1747-3242. eCollection 2022 Apr.
3
The Effect of Alcoholic Extract of on Biochemical and Histological Parameters in Rats.
[提取物名称]乙醇提取物对大鼠生化及组织学参数的影响 (原文中“of”后面缺少具体提取物名称)
J Toxicol. 2022 Mar 24;2022:6945745. doi: 10.1155/2022/6945745. eCollection 2022.
4
Association between serum potassium and risk of all-cause mortality among chronic kidney diseases patients: A systematic review and dose-response meta-analysis of more than one million participants.慢性肾脏病患者血清钾与全因死亡风险的关联:一项对超过100万参与者的系统评价和剂量反应荟萃分析
Food Sci Nutr. 2021 Jul 23;9(9):5312-5323. doi: 10.1002/fsn3.2478. eCollection 2021 Sep.
5
The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease.维持慢性肾脏病患者血钾正常和启用肾素-血管紧张素-醛固酮系统抑制剂治疗的价值。
BMC Nephrol. 2019 Jan 31;20(1):31. doi: 10.1186/s12882-019-1228-y.
6
Acute Renal Failure with Hyperkalemia Presenting as Recurrent Syncope.以反复晕厥为表现的急性肾衰竭伴高钾血症
Med J Armed Forces India. 2009 Oct;65(4):380-2. doi: 10.1016/S0377-1237(09)80111-1. Epub 2011 Jul 21.
7
Potassium-Binding Agents for the Clinical Management of Hyperkalemia.用于高钾血症临床管理的钾结合剂
P T. 2016 Jan;41(1):43-50.
8
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.慢性肾脏病患者的血清钾、终末期肾病与死亡率
Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25.
9
Mild hyperkalemia and low eGFR a tedious recipe for cardiac disaster in the elderly: an unusual reversible cause of syncope and heart block.轻度高钾血症和低估算肾小球滤过率对老年人来说是引发心脏灾难的棘手因素:一种导致晕厥和心脏传导阻滞的不寻常可逆病因。
Heart Int. 2011;6(2):e12. doi: 10.4081/hi.2011.e12. Epub 2011 Oct 26.
10
The positive predictive value of a hyperkalemia diagnosis in automated health care data.自动化医疗保健数据中高钾血症诊断的阳性预测值。
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1204-8. doi: 10.1002/pds.2030.